Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $48.2300 (2.36%) ($48.2300 - $48.3200) on Mon. Dec. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 73 | Latest Price | $48.2300(2.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.8% a day on average for past five trading days. | Weekly Trend | IOVA advances 4.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(43%) IWO(42%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.73% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-12%) TBT(-6%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $47.1(2.4%) | 10 Day Moving Average | $47.8(0.9%) | 20 Day Moving Average | $44.38(8.68%) | To recent high | -3.7% | To recent low | 71.8% | Market Cap | $7.063b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |